Szmigielski A, Guidotti A
Neurochem Res. 1979 Apr;4(2):189-200. doi: 10.1007/BF00964143.
The rat cerebellum contains a significant amount of cGMP-dependent protein kinase, cAMP-dependent and cyclic nucleotide-independent protein kinase, and a large concentration of protein kinase inhibitors. These inhibitors are thermostable proteins which can be separated by gel chromatography into two molecular forms: the type 1 and type 2 inhibitors of protein kinase (14). The type 1 inhibitor blocks the rat cerebellar cAMP-dependent protein kinase activity while the type 2 inhibitor blocks the cGMP-dependent protein kinase, the cAMP-dependent protein kinase, and the cyclic nucleotide-independent protein kinases. The activity of the type 2 inhibitor increased or decreased in opposite direction to changes of cerebellar cGMP content generated by injection of 10 mg/kg harmaline 2.5 mg diazepam. No changes of type 1 inhibitor were observed under these conditions. The drug-induced shift of type 2 inhibitor of protein kinase was not mediated by changes in protein synthesis because it persisted after pretreatment with cycloheximide. These results are compatible with the hypothesis that cGMP modulates phosphorylation in cerebellum by changing the relationship between cGMP-dependent protein kinase and type 2 inhibitor content.
大鼠小脑含有大量依赖环磷酸鸟苷(cGMP)的蛋白激酶、依赖环磷酸腺苷(cAMP)的蛋白激酶和不依赖环核苷酸的蛋白激酶,以及高浓度的蛋白激酶抑制剂。这些抑制剂是热稳定蛋白,可通过凝胶色谱法分离为两种分子形式:蛋白激酶1型和2型抑制剂(14)。1型抑制剂可阻断大鼠小脑依赖cAMP的蛋白激酶活性,而2型抑制剂可阻断依赖cGMP的蛋白激酶、依赖cAMP的蛋白激酶以及不依赖环核苷酸的蛋白激酶。注射10mg/kg去氢骆驼蓬碱、2.5mg地西泮后,小脑cGMP含量发生变化,2型抑制剂的活性则呈相反方向增减。在此条件下,未观察到1型抑制剂有变化。药物诱导的蛋白激酶2型抑制剂的变化并非由蛋白质合成的改变介导,因为用环己酰亚胺预处理后该变化仍然存在。这些结果与以下假设相符,即cGMP通过改变依赖cGMP的蛋白激酶与2型抑制剂含量之间的关系来调节小脑中的磷酸化作用。